UNSPSC 51282949: Trovafloxacin

This classification denotes a quinolone antibiotic with the molecular formula C20H15F3N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9F388J00UK, chemically known as cp-99,219 but generally known as trovafloxacin, which bears US NIH Compound Identifier 62959. European Medicines Agency schedules Trovafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11350MIG.

UNSPSC 51282949 Trovafloxacin is a Commodity code that nominally specifies a single fluoroquinolone antibiotic product, but recent state and local procurement activity shows minimal direct solicitation for trovafloxacin itself. Instead, the code appears incidentally tagged across broader pharmaceutical and medical supply procurements. State and local issuing bodies—including county health departments, state health and human services commissions, municipal fire departments, and cooperative purchasing alliances—are actively buying generic pharmaceuticals, over-the-counter products, naloxone and drug deactivation systems, and emergency medical supplies through multi-source vendor contracts and standing agreements. The work involves securing manufacturers or authorized distributors to supply identified pharmaceutical products with specific National Drug Codes, managing wholesaler relationships, ensuring FDA and cGMP compliance, and delivering products to multiple facilities across jurisdictions on fixed or negotiated pricing models. Vendors must maintain comprehensive insurance, comply with the Drug Supply Chain Security Act, and meet shelf-life and expiration-date requirements.

Recent activity spans multiple states and cooperative purchasing regions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with products to be available by May 15, 2026 and contracts effective July 1, 2026. Texas Health and Human Services Commission posted a Request for Information on April 3, 2026 to explore direct-to-manufacturer pharmacy initiatives and vendor capabilities for prescription fulfillment. The City of Tampa's Purchasing Department solicited sealed bids (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract value of $700,000 and a 5 percent bid discount reserved for certified Small Local Business Enterprises. Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) to procure naloxone and drug deactivation systems annually with quarterly deliveries. The code shows limited direct demand for trovafloxacin specifically; procurement interest clusters around broad pharmaceutical aggregation contracts and emergency medical supply frameworks rather than single-product acquisitions.